MetaCap

Perrigo Company plc (PRGO)

NYSE: PRGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.55+0.55 (+3.93%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

PRGO stock chart

Technical analysis

Key statistics

All statistics
Market cap
$2.01B
P/E (TTM)
—
Forward P/E
6.07
EPS (TTM)
-$12.28
Dividend yield
7.97% ($1.16)
Ex-dividend date
Aug 28, 2026
52-week range
9.23 – 22.02
Day range
14.00 – 14.62
Volume / Avg
1.91M / 2.81M
Beta
—
Shares outstanding
138.37M
Next earnings
Nov 4, 2026

52-week range

$9.23$22.02

PRGO stock today

Perrigo (PRGO) closed at $14.55 on Oct 7, up 3.93% (+$0.55), versus the S&P 500's 0.22% decline. At this level, PRGO sits in the middle of its 52-week range of $9.23 to $22.02: 33.9% below the high and 57.6% above the low. PRGO is up 4.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 32.9%.

Perrigo has posted a net loss over the last twelve months (EPS of -$12.28), so its P/E ratio is not meaningful. Perrigo's next earnings report is expected on Nov 4, 2026. Perrigo pays an annual dividend of $1.16 per share, a 7.97% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Perrigo

Company profile

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Albert Ange Manzone
Headquarters
Dublin
Employees
8,100
Website
perrigo.com

Analyst forecast

Forecast

Consensus (5 analysts)

none

Avg. price target

$16.50+13.40%

  • Strong buy 1
  • Buy 1
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $14.00High $20.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Nov 4, 2026
EPS estimate
$0.57

Dividends

Dividend history
Annual dividend
$1.16
Dividend yield
7.97%
Last payment
$0.29
Ex-dividend date
Aug 28, 2026

Perrigo peers

Health Care sector
PRGO peer companies
CompanyPrice% ChgMarket capCompare
URGNUroGen Pharma Ltd.40.70-1.76%$1.99Bvs PRGO
SDGRSchrodinger Inc.27.29-5.57%$2.04Bvs PRGO
LKFTLakefront Biotherapeutics ADR30.00+2.32%$1.96Bvs PRGO
VRDNViridian Therapeutics Inc.18.28+0.33%$2.07Bvs PRGO
MLYSMineralys Therapeutics Inc.22.09+0.64%$1.95Bvs PRGO
ZYMEZymeworks Inc.26.53+3.43%$1.90Bvs PRGO
GPCRStructure Therapeutics Inc. ADR26.68-2.88%$1.90Bvs PRGO
AGIOAgios Pharmaceuticals Inc.31.79+0.22%$1.90Bvs PRGO

Indexes, lists and sector

Appears in lists

Perrigo stock FAQ

What is Perrigo's stock price today?

PRGO last traded at $14.55 as of Oct 7, 4:00 PM EDT, up 3.93% on the day. Prices are delayed at least 15 minutes.

Does Perrigo pay a dividend?

Yes. Perrigo pays $1.16 per share annually, a 7.97% yield. The most recent dividend of $0.29 had an ex-dividend date of Aug 28, 2026.

When is Perrigo's next earnings date?

Perrigo is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $0.57.

Who is Perrigo's CEO?

Mr. Albert Ange Manzone is the chief executive officer of Perrigo Company plc, which has about 8,100 employees.

Has PRGO ever split its stock?

Yes. The most recent PRGO stock split was a 2-for-1 split on Aug 26, 1993.

What is the PRGO 52-week high?

The 52-week high for PRGO is $22.02 and the 52-week low is $9.23. The stock is currently 33.9% below its high.

Compare PRGO